CME credits: 1.25 
Valid until: 23-11-2023 
Claim your CME credit at <a href="https://reachmd.com/programs/cme/new-agents-in-hypertension-the-brightn-trial/14372/">https://reachmd.com/programs/cme/new-agents-in-hypertension-the-brightn-trial/14372/</a> 


 
 In this program, expert faculty review and discuss real-world applications of the latest, practice-changing data across different therapeutic areas within cardiovascular medicine presented at the American Heart Association Scientific Session 2022.

CME credits: 1.25 Valid until: 23-11-2023 Claim your CME credit at https://reachmd.com/programs/cme/new-agents-in-hypertension-the-brightn-trial/14372/ In this program, expert faculty review and discuss real-world applications of the latest, practice-changing data across different therapeutic areas within cardiovascular medicine presented at the American Heart Association Scientific Session 2022.

CME credits: 1.25 
Valid until: 23-11-2023 
Claim your CME credit at <a href="https://reachmd.com/programs/cme/new-agents-in-hypertension-the-brightn-trial/14372/" rel="noopener noreferrer">https://reachmd.com/programs/cme/new-agents-in-hypertension-the-brightn-trial/14372/</a> 


 
 In this program, expert faculty review and discuss real-world applications of the latest, practice-changing data across different therapeutic areas within cardiovascular medicine presented at the American Heart Association Scientific Session 2022.

New Agents in Hypertension: The BrigHTN Trial

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.

Share New Agents in Hypertension: The BrigHTN Trial

Sign up to save your podcasts

New Agents in Hypertension: The BrigHTN Trial

New Agents in Hypertension: The BrigHTN Trial